Biognosys Archives | Be Korea-savvy

Home / Posts tagged Biognosys

Biognosys Launches Groundbreaking P2 Plasma Enrichment Technology for Unbiased, Deep Plasma Proteomics at ASMS 2024

The proprietary P2 Plasma Enrichment method leverages a novel single-well, single particle-type enrichment method to achieve market-leading performance for unbiased, deep mass spectrometry-based plasma proteomics P2 now offers excellent quantitation and higher throughput for large-cohort biomarker or drug discovery studies, and clinical, epidemiological or population proteomics research P2 Plasma Enrichment is available as a CRO [...]

Biognosys Launches Spectronaut 19 and Presents Advances with Its Research Platforms at the ASMS 2024 Annual Conference

Spectronaut® 19 offers significant improvements in identifications, candidate discovery, scalability for large-scale analysis, and support for novel workflows Novel TrueDiscovery® P2 Plasma Enrichment method offers market-leading performance and superior economics for unbiased, deep plasma proteomics New TrueTarget® high-throughput LiP-MS workflow enables large-scale drug target deconvolution screening with improved target identification DigitalProteome™ database and Proteoverse™ data exploration tool help [...]

Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research

Strategic partnership expands Biognosys’ services to include Alamar’s NULISA assays as well as joint scientific research in biofluid-based proteomics Complementary value of Biognosys’ DIA-MS unbiased proteomics platform and Alamar’s game-changing immunoassay platforms to be presented at the AACR 2024 Annual Meeting ZURICH, Switzerland and FREMONT, Calif., April 04, 2024 (Korea Bizwire) – Biognosys, a global [...]